Hybrid Quantum Machine Learning Platform for Early Disease Detection
Egreen Quanta · MedTech / BioTech / HealthTech · Software
The hardware barrier is removed by simulators, but a few-qubit quantum classifier rarely beats a classical model on standard medical data — take it as an honest methodology study, not as a disease-detection claim, and report the comparison straight.
Data: Public/Open
What it actually is
Classical machine learning does disease detection well but struggles with very high-dimensional biomedical data like genomics. Quantum machine learning might capture patterns classical models miss, but real quantum hardware is limited, so the ask is a hybrid quantum-classical platform — classical preprocessing feeding a quantum classifier running on a simulator — for early disease detection, benchmarked against a classical baseline.
What to build
A hybrid pipeline where classical feature engineering and dimensionality reduction prepare a biomedical dataset, then a quantum-enhanced classifier — a variational quantum classifier, quantum SVM or quantum neural network implemented in a quantum framework and run on a simulator — performs the detection, applied to a public dataset for a disease such as breast cancer or a cardiovascular condition, with an explainability module, a performance evaluation reporting accuracy, sensitivity and specificity, and a direct comparison against a classical model on the identical features.
Smallest thing that wins the room
Run the hybrid quantum classifier and a classical model on the same preprocessed cancer dataset and show the accuracy, sensitivity and specificity side by side, with the quantum circuit and its feature encoding visualised so the judge can see what the quantum layer actually does.
How crowded this one gets
A guess, projected from the 2025 statements — the last year where both the submission counts and the winners were published.
Quieter than 32% of the 226 · #155 of 226 by expected field
A normal-sized field. Your idea has to be good, not miraculous.
Why: company-sponsored statements drew the smallest fields of all.
This is a guess, not a fact
Nobody has published 2026’s numbers yet. This is an analysed estimate from last year’s pattern, so please do not take it as the truth — check the live counter on the SIH portal before you decide anything. The range covers the middle half of likely outcomes, so one statement in two lands outside it. Entry closes at 500 ideas per statement, so no range goes past that — a statement that reaches the cap fills and shuts rather than drawing an unlimited crowd. The model reads only three things a team can see before choosing — software or hardware, the theme, and what kind of body posted it — and those explain about a quarter of the variation in last year’s field sizes (R² 0.25 on held-out statements). Trust the band more than the number, and the ordering more than either. It cannot see how good your idea is, which is the part that actually decides it.
The scores
The number is the shorthand. The line under it is the reason.
Acceptance potential
2/5The honest problem is that hybrid QML on a handful of simulated qubits almost never beats a classical model on these standard datasets, so a rigorous benchmark tends to show the quantum layer adding nothing — an important finding but not the win teams expect, and disease-detection framing invites clinical scrutiny the QML novelty cannot satisfy.
Feasibility
3/5Qiskit and PennyLane run variational quantum classifiers on simulators without any quantum hardware, and public medical datasets like the Wisconsin breast cancer set are standard, but simulating quantum circuits scales badly so you are limited to very few qubits and therefore very few features, which constrains what is achievable.
Innovation scope
3/5Hybrid QML architectures are named in the description and are an established pattern, so your room is in the feature encoding, the circuit design and the honesty of the comparison rather than in the concept.
Clarity
4/5The objectives are numbered and name the model families, the required modules and the mandatory classical baseline comparison, so the deliverable is well specified.
Effort
HeavyThe classical preprocessing, the quantum circuit design and training on a simulator, and the explainability and benchmark layers are focused but demanding, and simulator runtimes add friction.
Demo-ability
MediumThe side-by-side metric comparison and a visualised quantum circuit demo cleanly, but the result is a table plus a diagram rather than anything visually dramatic.
In its favour
- Green flag: PennyLane and Qiskit simulate the quantum circuits, so no quantum hardware is needed and the platform runs on a laptop
- Green flag: Public biomedical datasets like the Wisconsin breast cancer set are clean and standard, removing all data-sourcing risk
- Green flag: The mandatory classical baseline gives you an honest evaluation frame built into the requirement
- Green flag: The quantum-ML framing thins the field sharply, since few teams are comfortable with variational circuits
Against it
- Red flag: Simulating quantum circuits scales exponentially, so you are confined to a few qubits and a few features, which caps the problem far below where classical models already excel
- Red flag: On these standard datasets a classical model typically matches or beats the quantum classifier, so a fair benchmark often shows no quantum advantage
- Red flag: Framing it as disease detection invites clinical validation questions that a small-qubit proof-of-concept cannot answer
- Red flag: Explainability of a variational quantum circuit is genuinely hard, and a superficial saliency plot will not satisfy the explainability requirement
What you will be writing
- PennyLane or Qiskit variational quantum classifier
- Quantum feature encoding (angle / amplitude embedding)
- Classical dimensionality reduction (PCA) preprocessing
- Wisconsin breast cancer / UCI biomedical datasets
- Classical SVM / gradient boosting baseline
- Quantum circuit visualisation
- Quantum machine learning
- Medical diagnosis
- Hybrid quantum-classical computing
Prior art to read before you start
variational quantum classification · hybrid QML for tabular biomedical data · quantum versus classical benchmarking
Analysed by Claude Opus. Every score above is a judgment call with its reasoning attached — kindly cross-check this against the official statement on the SIH portal before your team commits to it.